EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Glucocorticoid-induced leucine zipper is a primary checkpoint molecule that establishes a virus-specific CD8+ T-cell activation threshold

Taylah J Bennett, Charlene Lam, Jessie O'Hara, Vibha A V Udupa, Daniel Thiele, Jason K C Lee, Adele Barugahare, Jasmine Li, Nicole L La Gruta, Sarah A Jones, Brendan E Russ, Stephen J Turner

The Journal of Immunology · 09.02.2026 · 215 (2)

DOI: 10.1093/jimmun/vkaf353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 01.03.2026. Verfasst von Taylah J Bennett und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunity Program, The Biomedical Discovery Institute, Monash University, Clayton, VIC, Australia. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Lymphocyte Activation, Orthomyxoviridae Infections, Transcription Factors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Health and Medical Research Council of Australia, Australian Research Council Discovery, Australian Postgraduate Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Naïve CD8+ T-cell activation needs to overcome a signaling threshold to initiate the resulting program of T cell proliferation and differentiation. While the strength of T-cell receptor (TCR) signaling and co-stimulation are known to dictate T-cell responsiveness, the role of other factors that determine strength of signal is not well studied. Glucocorticoid-induced leucine zipper (GILZ) is a regulatory protein that serves to dampen activation signals in several leukocyte populations. Here we demonstrate that GILZ is highly expressed in murine naïve CD8+ T cells and downregulated with activation. GILZ deficiency increased accumulation of antigen-specific CD8+ T-cell responses in a mouse model of influenza A virus infection, and this correlated with greater responsiveness to low-affinity ligands. GILZ-deficient CD8+ T cells were able to better engage optimal effector transcriptional programs at lower signaling thresholds, highlighting GILZ as a key checkpoint for naïve CD8+ T cell activation. Importantly, GILZ deficiency did not impact memory T cell formation or recall responses to influenza A virus infection. These data demonstrate that GILZ acts as an important naïve CD8+ T cell checkpoint by establishing a threshold for initial activation. Modulation of GILZ could be beneficial in improving CD8+ T cell responses against low-affinity ligands, particularly like those found in the context of tumor antigens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesLymphocyte ActivationOrthomyxoviridae InfectionsTranscription FactorsInfluenza A virusAnimalsMiceMice, Inbred C57BLMice, KnockoutSignal TransductionImmunologic Memory

Stichwörter der Autor:innen

CD8+ T cellT-cell memoryinfluenza virustranscription factor

Substanzen

Transcription FactorsDsip1 protein, mouse

Autor:innen und Institutionen

  • Department of Microbiology, Immunity Program, The Biomedical Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia.
  • Department of Medicine, The University of Melbourne, Parkville, VIC, Australia.
  • Department of Biochemistry and Molecular Biology, Immunity Program, The Biomedical Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Bioinformatics Platform, The Biomedical Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Department of Medicine, Centre for Inflammatory Disease, School of Clinical Sciences, Monash University, Clayton, VIC, Australia.

Förderung

  • National Health and Medical Research Council of Australia
  • Australian Research Council Discovery
  • Australian Postgraduate Award

Zitieren

APA

Bennett, T. J., Lam, C., O'Hara, J., Udupa, V. A. V., Thiele, D., Lee, J. K. C., Barugahare, A., Li, J., La Gruta, N. L., Jones, S. A., Russ, B. E., & Turner, S. J. (2026). Glucocorticoid-induced leucine zipper is a primary checkpoint molecule that establishes a virus-specific CD8+ T-cell activation threshold. The Journal of Immunology, 215(2). https://doi.org/10.1093/jimmun/vkaf353

Vancouver

Bennett TJ, Lam C, O'Hara J, Udupa VAV, Thiele D, Lee JKC, et al. Glucocorticoid-induced leucine zipper is a primary checkpoint molecule that establishes a virus-specific CD8+ T-cell activation threshold. The Journal of Immunology. 2026;215(2). doi:10.1093/jimmun/vkaf353

BibTeX
@article{Bennett2026,
  author = {Bennett, Taylah J and Lam, Charlene and O'Hara, Jessie and Udupa, Vibha A V and Thiele, Daniel and Lee, Jason K C and Barugahare, Adele and Li, Jasmine and La Gruta, Nicole L and Jones, Sarah A and Russ, Brendan E and Turner, Stephen J},
  title = {Glucocorticoid-induced leucine zipper is a primary checkpoint molecule that establishes a virus-specific CD8+ T-cell activation threshold},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {2},
  doi = {10.1093/jimmun/vkaf353}
}
Kostenlos starten →